Evaluation of the Diagnostic Accuracy of Carbon Nanoparticle Suspensions in Sentinel Lymph Node Biopsy of Breast Cancer: A Systematic Review and Meta-analysis

Document Type : Review Article

Authors

1 School of Medicine, Faculdade de Medicina da Universidade do Porto-FMUP, Porto, Portugal

2 School of Medicine, Düzce University, Düzce, Turkey

Abstract

Background and aim: The present study investigated the diagnostic accuracy of carbon nanoparticle suspensions in sentinel lymph node biopsy of breast cancer.
Material and methods: The present study used the PRISMA 2020-27-item checklist. To find the studies conducted in line with the purpose of the study, PubMed, Web of Science, Scopus, Science Direct, Web of Knowledge, EBSCO, Wiley, ISI, Elsevier, Embase databases, and Google Scholar search engines were reviewed from 2013 to July 2023. Meta-analysis used effect size (sensitivity and specificity) with a 95% confidence interval. The Egger test and funnel plot checked the publication bias, and data analysis was done using STATA/MP-V.17 software.
Results: Ten articles with 799 patients were reviewed. The sensitivity of carbon nanoparticle suspensions in sentinel lymph node biopsy was 91% (ES, 95%CI; 78%,100%. I2=0.00%; p=1.00). The specificity of carbon nanoparticle suspensions in sentinel lymph node biopsy was 99% (ES, 95% CI; 86%,100%. I2=0.00%; p=1.00).
Conclusions: Carbon nanoparticle suspensions have the highest sensitivity and specificity in sentinel lymph node breast cancer biopsy.

Keywords

Main Subjects

References

[1] Iacoviello L, Bonaccio M, de Gaetano G, Donati MB. Epidemiology of breast cancer, a paradigm of the “common soil” hypothesis. InSeminars in cancer biology 2021;72:4-10. https://doi.org/10.1016/j.semcancer.2020.02.010.
[2] Wellings E, Vassiliades L, Abdalla R. Breast cancer screening for high-risk patients of different ages and risk-which modality is most effective?. Cureus. 2016;8(12). https://doi.org/10.7759/cureus.945.
[3] Giammarile F, Vidal-Sicart S, Paez D, Pellet O, Enrique EL, Mikhail-Lette M, et al. Sentinel Lymph Node Methods in Breast Cancer. InSeminars in Nuclear Medicine 2022;52(5):551-560. https://doi.org/10.1053/j.semnuclmed.2022.01.006.
[4] Del Bianco P, Zavagno G, Burelli P, Scalco G, Barutta L, Carraro P, et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella–GIVOM Italian randomised clinical trial. European Journal of Surgical Oncology (EJSO). 2008;34(5):508-13. https://doi.org/10.1016/j.ejso.2007.05.017.
[5] Campbell I, Wetzig N, Ung O, Espinoza D, Farshid G, Collins J, et al. 10-Year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection. The Breast. 2023;70:70-5. https://doi.org/10.1016/j.breast.2023.06.009/
[6] Liu Y, Ye F, Wang Y, Zheng X, Huang Y, Zhou J. Elaboration and validation of a nomogram based on axillary ultrasound and tumor clinicopathological features to predict axillary lymph node metastasis in patients with breast cancer. Frontiers in Oncology. 2022;12:845334. https://doi.org/10.3389/fonc.2022.845334.
[7] Godazandeh G, Alizadeh-Navaei R, Shamshirian A, Heydari K, Shojaee L. Diagnostic value of intraoperative frozen section in breast-conserving surgery: a systematic review and meta-analysis. International Journal of Cancer Management. 2021;14(11):e114082. https://doi.org/10.5812/ijcm.114082.
[8] Ahn JH, Park JM, Choi SB, Go J, Lee J, Kim JY, et al. Early experience of robotic axillary lymph node dissection in patients with node-positive breast cancer. Breast Cancer Research and Treatment. 2023;198(3):405-12. https://doi.org/10.1007/s10549-022-06760-8.
[9] Riis M. Modern surgical treatment of breast cancer. Annals of medicine and surgery. 2020;56:95-107. https://doi.org/10.1016/j.amsu.2020.06.016.
[10] Yang X, Li Y, Ren XT, Fan L, Hua B. Carbon nanoparticles localized clipped node dissection combined with sentinel lymph node biopsy with indocyanine green and methylene blue after neoadjuvant therapy in node positive breast cancer in China: initial results of a prospective study. World Journal of Surgical Oncology. 2023;21(1):1-9. https://doi.org/10.1186/s12957-023-03120-8.
[11] Chirappapha P, Chatmongkonwat T, Lertsithichai P, Pipatsakulroj W, Sritara C, Sukarayothin T. Sentinel lymph node biopsy after neoadjuvant treatment of breast cancer using blue dye, radioisotope, and indocyanine green: prospective cohort study. Annals of Medicine and Surgery. 2020;59:156-60. https://doi.org/10.1016/j.amsu.2020.09.030.
[12] Yang J, Xu L, Liu P, Du Z, Chen J, Liang F, et al. Accuracy of sentinel lymph node biopsy in breast cancer: pitfalls in the application of single tracers. Cancer Management and Research. 2020;12:3045-51.
[13] Cserni G, Maguire A, Bianchi S, Ryska A, Kovács A. Sentinel lymph node assessment in breast cancer—an update on current recommendations. Virchows Archiv. 2022;480(1):95-107. https://doi.org/10.1007/s00428-021-03128-z.
[14] Yan J, Zheng X, Liu Z, Yu J, Deng Z, Xue F, et al. A multicenter study of using carbon nanoparticles to show sentinel lymph nodes in early gastric cancer. Surgical endoscopy. 2016:1294-300. https://doi.org/10.1007/s00464-015-4358-8.
[15] Lu Y, Wei JY, Yao DS, Pan ZM, Yao Y. Application of carbon nanoparticles in laparoscopic sentinel lymph node detection in patients with early-stage cervical cancer. PLoS One. 2017;12(9):e0183834. https://doi.org/10.1371/journal.pone.0183834.
[16] Tian Y, Yang P, Lin Y, Hu Y, Deng H, Ma W, et al. Assessment of carbon nanoparticle suspension lymphography–guided distal gastrectomy for gastric cancer. JAMA Network Open. 2022;5(4):e227739.https://doi.org/10.1001/jamanetworkopen.2022.7739.
[17] Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. International journal of surgery. 2021;88:105906. https://doi.org/10.1016/j.ijsu.2021.105906.
[18] Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ open. 2016;6(11):e012799. http://dx.doi.org/10.1136/bmjopen-2016-012799.
[19] Huang QX, Huang XW. Quadas-2 tool for quality assessment in diagnostic meta-analysis. Ann. Palliat. Med. 2022;11(5):1844-5. https://dx.doi.org/10.21037/apm-22-204.
[20] Lin N, Liu W, Wang M, Zhou W, Zheng S, Yang J, et al. Ultrasound-assisted carbon nanoparticle labeling of neoadjuvant chemotherapy for breast-conserving surgery in breast cancer. Quantitative Imaging in Medicine and Surgery. 2023;13(3):1825-37. https://doi.org/10.21037/qims-22-361.
[21] Wei N, Hou J, Chen J, Dai M, Du K, Wang S, et al. Sentinel lymph node biopsy with carbon nanoparticle suspension after neoadjuvant chemotherapy for breast cancer patients. The Annals of The Royal College of Surgeons of England. 2021;103(10):752-6. https://doi.org/10.1308/rcsann.2021.0084.
[22] Gao HY, Dai JB, Xue J. Carbon Nanoparticle Suspension With Methy Blue Injection in Sentinel Lymph Node Biopsy for Breast Cancer Patients. J Chin Oncol. 2018;24(9):892-5.
[23] MU S, Wang L, LI D, Wang Y, Xiao E, Lou C. Application value of nano carbon lymph tracing technique in the radical resection of gallbladder cancer: a prospective study. Chinese Journal of Digestive Surgery. 2018:237-43.
[24] Yang SX, Wei WS, Jiang QH, Zhou YF, Qu W, Tu JH, et al. Analysis of 246 sentinel lymph node biopsies of patients with clinical primary breast cancer by application of carbon nanoparticle suspension. Journal of Obstetrics and Gynaecology Research. 2018;44(6):1150-7. https://doi.org/10.1111/jog.13635.
[25] Zhang L, Huang Y, Yang C, Zhu T, Lin Y, Gao H, et al. Application of a carbon nanoparticle suspension for sentinel lymph node mapping in patients with early breast cancer: a retrospective cohort study. World Journal of Surgical Oncology. 2018;16:1-6. https://doi.org/10.1186/s12957-018-1414-6.
[26] Zou W, Bai Y, Wang X, Cheng K, Sun H, WU M, et al. Comparison between indocyanine green fluorescence imaging plus methylene blue and plus carbon nanoparticles suspension injection for sentinel lymph node biopsy in breast cancer patients. The Journal of Practical Medicine. 2017:1857-60.
[27] Tu JH, Zhang H, Lu YH, Wang S, Ling LJ. Feasibility of Nanogate Carbon as Agent for Sentinel Lymph Node Biospy in Early Breast Cancer Patients. Chin J Exp Surg. 2015;32(12):3147-50.
[28] Wu X, Lin Q, Chen G, Lu J, Zeng Y, Chen X, et al. Sentinel lymph node detection using carbon nanoparticles in patients with early breast cancer. PLoS One. 2015;10(8):e0135714. https://doi.org/10.1371/journal.pone.0135714.
[29] Lei S, YU X, Xie C, JI M, Lei Q. Application of carbon nanoparticle in the axillary sentinel lymph node biopsy for breast cancer. Chinese Journal of Postgraduates of Medicine. 2014:1-3.
[30] Wang P, Shuai J, Leng Z, Ji Y. Meta-analysis of the application value of indocyanine green fluorescence imaging in guiding sentinel lymph node biopsy for breast cancer. Photodiagnosis and Photodynamic Therapy. 2023;43:103742. https://doi.org/10.1016/j.pdpdt.2023.103742.
[31] Xie P, Huang Y, Tang K, Wu X, Zeng C, Yang ST, et al. Carbon nanoparticles-Fe (II) complex for efficient theranostics of xenografted colonic tumor. Cancer Nanotechnology. 2023;14(1):38. https://doi.org/10.1186/s12645-023-00196-5.
[32] Xie P, Yang ST, Huang Y, Zeng C, Xin Q, Zeng G, et al. Carbon nanoparticles–Fe (II) complex for efficient tumor inhibition with low toxicity by amplifying oxidative stress. ACS applied materials & interfaces. 2020;12(26):29094-102. https://doi.org/10.1021/acsami.0c07617.
 
International Journal of Scientific Research in Dental and Medical Sciences
Volume 5, Issue 3 - Serial Number 3
September 2023
Pages 154-163

Files

History

  • Receive Date: 30 June 2023
  • Revise Date: 25 July 2023
  • Accept Date: 02 September 2023

Share

How to cite

Statistics